Wall Street analyst price targets, ratings consensus & upside potential · Updated Feb 28, 2026
Last 12 months price action with 12-month analyst target path
As of March 2, 2026, Global Medical REIT Inc. (GMRE) has a Wall Street consensus price target of $40.00, based on estimates from 22 covering analysts. With the stock currently trading at $37.20, this represents a potential upside of +7.5%. The company has a market capitalization of $499M.
Analyst price targets range from a low of $40.00 to a high of $40.00, representing a 0% spread in expectations. The median target of $40.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 13 analysts rating the stock as a Buy or Strong Buy,9 rating it Hold, and 0 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, GMRE trades at a trailing P/E of 120.0x and forward P/E of 620.0x. Analysts expect EPS to grow -67.9% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $37.20, with bear and bull scenarios of $-88.99 and $478.87 respectively. Model confidence stands at 19/100, suggesting limited visibility into future performance.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationSee how GMRE stacks up against sector leader Welltower Inc..
Start ComparisonThe consensus price target for GMRE is $40, close to the current price of $37.2 (7.5% implied move). Based on 22 analyst estimates, the stock appears fairly valued near current levels.
GMRE has a consensus rating of "Buy" based on 22 Wall Street analysts. The rating breakdown is predominantly bullish, with 13 Buy/Strong Buy ratings. The consensus 12-month price target of $40 implies 7.5% upside from current levels.
At a forward P/E of 620x, GMRE trades at a premium valuation. The consensus price target of $40 (7.5% upside) suggests analysts may view current valuations as stretched.
The most bullish Wall Street analyst has a price target of $40 for GMRE, while the most conservative target is $40. The consensus of $40 represents the median expectation. Our quantitative valuation model projects a bull case target of $479 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
GMRE is well covered by analysts, with 22 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 13 have Buy ratings, 9 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month GMRE stock forecast based on 22 Wall Street analysts shows a consensus price target of $40, with estimates ranging from $40 (bear case) to $40 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $37, with bear/bull scenarios of $-89/$479.
Our quantitative valuation model calculates GMRE's fair value at $37 (base case), with a bear case of $-89 and bull case of $479. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 19/100.
GMRE trades at a forward P/E ratio of 620.0x based on next-twelve-months earnings estimates compared to a trailing P/E of 120.0x. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
GMRE appears fairly valued according to analysts, with a "Buy" rating and minimal upside to the $40 target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
GMRE analyst price targets range from $40 to $40, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $40 consensus represents the middle ground. Our model's $-89-$479 range provides an independent fundamental perspective.